Back
IGM Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
53
IGMS
IGM Biosciences
Last Price:
9.29
Seasonality Move:
12.17%
Sell
37
NBY
NovaBay Pharmaceuticals
Last Price:
0.12
Seasonality Move:
1.9%
Buy
53
IGM Biosciences (IGMS)
is a Buy
Is IGM Biosciences a Buy, Sell or Hold?
- The current IGM Biosciences [IGMS] share price is $9.49. The Score for IGMS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- IGMS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.10. The Score for NBY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IGMS Stock Price Chart
What is IGM Biosciences's stock price today?
-
The IGM Biosciences share price today is $9.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGMS is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
IGMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 51.72 | Buy |
| Chaikin Money Flow: | -126687 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.97 - 9.89) | Buy |
| Bollinger Bands (100): | (8.38 - 12.66) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 60.18 | Buy |
| Chaikin Money Flow: | 10209132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.07 - 0.09) | Buy |
| Bollinger Bands (100): | (0.1 - 0.18) | Sell |
IGMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.59 | Sell |
| 20-day SMA: | 8.95 | Buy |
| 50-day SMA: | 9.38 | Buy |
| 200-day SMA: | 8.5 | Buy |
| 8-day EMA: | 9.44 | Buy |
| 20-day EMA: | 9.29 | Buy |
| 50-day EMA: | 9.55 | Sell |
| 200-day EMA: | 10.08 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Buy |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.09 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.51 | Sell |
IGM Biosciences Earnings Growth & IGMS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.07 per share, an increase this year of $2.13 per share, and a decrease next year of $0.06 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
IGM Biosciences Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||